Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Ventyx Biosciences (VTYX) News Today

Ventyx Biosciences logo

VTYX Latest News

Lilly-branded insulin pen and vial on a desk beside a digital scale and measuring tape, representing diabetes treatment.
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns (VTYX)
After tanking on Novo's "Wegovy Pill" release, Eli Lilly shares reversed course. See why investors may like its acquisition of Ventyx Biosciences.
UBS downgrades Ventyx Biosciences (VTYX)
Eli Lilly Nears Deal for Biotech Ventyx
Wells Fargo Remains a Buy on Ventyx Biosciences (VTYX)
Ventyx Provides Clinical and Corporate Updates
Ventyx Biosciences: Why Caution Should Remain
Ventyx Biosciences Reports Q3 2025 Financial Results
Get Ventyx Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for VTYX and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VTYX Media Mentions By Week

VTYX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VTYX
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

VTYX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VTYX Articles
This Week

0

2

VTYX Articles
Average Week

Get the Latest News and Ratings for VTYX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:VTYX) was last updated on 5/17/2026 by MarketBeat.com Staff.
From Our Partners